October 03, 2023
The Therapeutics Accelerator (the ‘Accelerator’) will identify, fund and advance innovative projects from academic partners in the U.K. and U.S. with the goal to deliver 40 new potentially life-changing therapies for rare diseases into clinical trials over the next ten years, targeting multiple approvals in key...
Continue ReadingNovember 10, 2020
Cleveland, Ohio, USA – Harrington Discovery Institute at University Hospitals and Case Western Reserve University School of Medicine have issued a call for proposals for the 2021 Harrington-MSTP (Medical Scientist Training Program) Scholar Award to help the next generation of physician-scientists advance their discoveries... Continue Reading
October 23, 2020
CLEVELAND — Traumatic brain injury (TBI) is a leading cause of cognitive impairment that affects millions of people worldwide. Despite growing awareness about the debilitating and lifelong progressive consequences of TBI, there are currently no treatments that slow the deteriorative process. TBI survivors are currently... Continue Reading
October 14, 2020
October 14, 2020, CLEVELAND, Ohio USA – The Harrington Discovery Institute® at University Hospitals in Cleveland, Ohio, and its registered charity Fund for Cures UK, Ltd., together with Morgan Stanley GIFT (Global Impact Funding Trust) Cures, announced five winners in the inaugural Harrington UK Rare Disease Scholar Award... Continue Reading
August 10, 2020
As novel coronavirus cases continue to increase in the United States and throughout the world, the , in collaboration with , is raising funds for research to bring an end to the COVID-19 pandemic.Officials confirm the money will support Harrington’s COVID-19 Rapid Response Initiative to provide critical funding to selected... Continue Reading
July 21, 2020
New York/Cleveland, OH, July 21, 2020 – A licensing agreement between drug maker Acadia Pharmaceuticals and Vanderbilt University represents a major milestone for the ADDF-Harrington Scholar Award Program, which provided funding and pharmaceutical expertise to support the research in the early phases. Acadia and Vanderbilt... Continue Reading
July 15, 2020
July 15, 2020, CLEVELAND, Ohio USA – National and international nominations are being sought for the 2021 Harrington Prize for Innovation in Medicine, which honors a physician-scientist who has moved science forward with achievements notable for innovation, creativity and the potential for clinical application. The deadline... Continue Reading
July 08, 2020
NEW YORK, NY, July 8, 2020 – The Alzheimer’s Drug Discovery Foundation (ADDF) and Harrington Discovery Institute at University Hospitals have granted , of Mayo Clinic Rochester, an .Dr. Trushina has been awarded $600,000 for her late stage preclinical research on new drug candidates that show promise in restoring... Continue Reading
July 08, 2020
July 8, 2020, CLEVELAND and NEW YORK CITY – Coronavirus cases continue to increase in the United States and throughout the world. Harrington Discovery Institute at University Hospitals, in collaboration with Morgan Stanley GIFT (Global Impact Funding Trust) Cures, is raising funds for research to bring an end to the COVID-19... Continue Reading
June 19, 2020
When a research project over 15 years in the making resulted in a drug that improved pulmonary function and oxygen delivery, researcher James D. Reynolds thought the drug could also help COVID-19 patients with severely compromised lung and heart function. Reynolds, Professor of Anesthesiology & Perioperative Medicine, was... Continue Reading
June 11, 2020
June 11, 2020, CLEVELAND, Ohio USA – The Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, in collaboration with Morgan Stanley GIFT (Global Impact Funding Trust) Cures, today announced 12 award winners in the COVID-19 Rapid Response Initiative. These award recipients will receive grant funding and... Continue Reading